The Difference Between Functional and Structural Disease
There is a meaningful clinical distinction between disease that operates at the functional level — disrupting the regulatory processes of organ systems without permanently altering the underlying tissue — and disease that has moved into the structural level, where the quality and integrity of tissue itself has been changed. Functional disease is generally more responsive to correction, because the underlying tissue retains its capacity to normalise once the functional disruption is removed. Structural disease requires additional intervention, because the tissue itself has changed in ways that impair its own healing capacity and contribute to ongoing disease activity.
In HS, both levels are typically involved — but the relative contribution of each shifts dramatically with disease duration and stage. Early HS is predominantly functional: the internal regulatory disruptions are driving lesion activity, but the tissue architecture in affected areas, while compromised, retains substantial integrity and healing potential. Long-standing HS, particularly at Hurley Stage II and III, has a significant structural dimension: the fibrosis, the disrupted follicular architecture, the scarred and thickened skin, the established sinus tracts — these represent changes to the tissue itself that are not resolved by functional correction alone. They require specific, tissue-directed restoration work, sustained over a period that reflects the pace of actual tissue regeneration.
"Unless the underlying causes are addressed, the condition may continue to recur despite treatment."
The Ayurvedic Framework of Dhatu Involvement
Ayurvedic clinical tradition describes seven tissue layers — the Saptadhatu — through which disease progressively deepens as it moves from functional to structural involvement. These are not simply anatomical layers; they represent qualitatively different levels of tissue function, each more deeply embedded in the body's structural architecture than the one before, and each more challenging to correct once pathological involvement has been established.
The progression from one Dhatu to the next is not automatic — it depends on the sustained presence of the pathological process over time, and on the failure of earlier interventions to arrest the progression. Each level of Dhatu involvement adds both structural complexity and a new dimension of treatment requirement. Understanding which Dhatus are involved in a patient's HS is not academic classification — it directly determines what treatment must accomplish at the tissue level.
Rasa and Rakta — The First Two Tissue Layers
The first two Dhatus involved in HS progression are Rasa (plasma and lymphatic fluid — the nutrient-rich medium in which cells exist) and Rakta (blood and the inflammatory mediators circulating within it). In functional HS, these two layers are the primary site of involvement: the systemic inflammatory load circulates in the Rasa, disrupting the nutritive quality of the medium reaching all tissues; the blood carries the elevated inflammatory markers and hormonal imbalances that characterise active HS. Correction at the Rasa and Rakta level — reducing the circulating inflammatory load, improving the quality of the nutritive medium, rebalancing the hormonal environment — is the primary target of early-stage treatment. This is what the detoxification and inflammation-reduction phases of structured correction accomplish.
Mamsa — The Third Layer
Mamsa — the muscle and soft connective tissue layer — becomes involved when the disease has been established long enough for the inflammatory process to begin altering the quality of the connective tissue in affected areas. In HS, this corresponds to the early fibrosis, the thickening and hardening of the skin in repeatedly affected zones, and the beginning of the structural changes that make the local tissue environment increasingly hostile to healing. When Mamsa is involved, functional correction alone — however thorough — is not sufficient to restore normal tissue quality. Active tissue restoration directed at the connective tissue layer is required: supporting the remodelling of fibrosed tissue, restoring normal connective tissue architecture, and improving the vascular and lymphatic supply to the affected areas.
Meda and Asthi — The Fourth and Fifth Layers
In severe, long-standing HS — particularly in patients with significant metabolic involvement, obesity, or advanced Hurley Stage III disease — the disease may involve the Meda Dhatu (adipose tissue and lipid metabolism) and, in rare cases, begin to approach the Asthi layer (bone and deeper structural tissues). Meda involvement in HS is clinically relevant because adipose tissue is itself an active inflammatory organ, producing its own inflammatory mediators and contributing directly to the systemic inflammatory burden. In patients with significant visceral adiposity and HS, the Meda Dhatu is not a passive bystander — it is an active driver of the disease's inflammatory component. Correction at this level requires metabolic intervention: specifically, improving insulin sensitivity, reducing visceral inflammation, and supporting the normalisation of adipose tissue function as an inflammatory regulator rather than an inflammatory amplifier.
The concept of Dhatu Kshaya — tissue depletion — is particularly relevant to long-standing HS. Sustained inflammation at the tissue level does not simply damage tissue; it depletes the nutritive quality of the Dhatu, reducing its capacity to regenerate effectively between episodes of inflammation. This is why the healing response in chronic HS is typically slower and less complete than in early-stage disease — not because the body has lost its capacity to heal, but because the nutritive substrate available to support healing has been depleted by years of sustained inflammatory demand. Rasayana therapy in the Ayurvedic framework — the use of deeply restorative compounds that specifically address Dhatu depletion and support regenerative capacity — is the clinical response to this dimension of the disease. In the EPOH approach, tissue restoration in the later phases of treatment incorporates this Rasayana principle: not simply reducing the inflammatory burden, but actively restoring the nutritive quality of the Dhatu to support genuine regeneration.
Why Deep-Seated Pathology Resists Surface-Level Treatment
The clinical significance of Dhatu involvement is that it explains a specific pattern that patients with long-standing HS commonly experience: the frustrating gap between what they are doing — following appropriate dietary changes, reducing inflammatory triggers, maintaining the correction programme — and what the skin is doing. Even when the internal correction is genuinely occurring and the systemic inflammatory burden is reducing, the structural changes in the affected tissue continue to generate some level of lesion activity — because those structural changes are not resolved by functional correction. They require time, and specific tissue-directed support, to resolve.
This is not a failure of the treatment. It is a feature of deep-seated pathology that needs to be understood and anticipated. The functional correction changes the systemic environment in which the tissue exists. But the tissue itself — altered over years of sustained inflammation — has its own timeline of restoration that operates at the pace of actual tissue regeneration, which is slower than the reduction of systemic inflammation. The two processes — internal correction and tissue restoration — must proceed simultaneously, with the tissue restoration sustained long enough for the structural changes to genuinely resolve rather than merely improve.
The Sinus Tract Problem
Sinus tracts — the tunnelling structures beneath the skin that characterise advanced HS — represent a specific and important dimension of deep-seated structural pathology. A sinus tract is not simply a consequence of previous inflammation; it is a structure that has its own inflammatory microenvironment, its own chronic low-grade activity, and its own contribution to ongoing lesion generation in its vicinity. It is, in the Ayurvedic framework, an established Srotorodha — a pathological obstruction of a structural channel — that generates local inflammatory activity independently of the systemic drivers that originally produced it.
This is why sinus tract management requires a different level of intervention than nodule or abscess management. Sinus tracts that are continuously draining, causing significant discomfort, or contributing to rapid new lesion development in adjacent areas may require surgical consideration. In these cases, the surgical removal of the established structural lesion is not in conflict with internal correction — it removes a locally active driver of inflammation while the internal correction addresses the systemic drivers that would otherwise generate new tracts. The two interventions are complementary, not competing. The key is ensuring that internal correction proceeds in parallel — not after surgical healing alone — so that the systemic environment that produced the tracts is genuinely changed.
Recognising Deep-Seated Involvement — Clinical Indicators
Several clinical features suggest that a patient's HS has significant structural — rather than primarily functional — involvement that requires tissue-directed correction in addition to systemic work. These include: the presence of established sinus tracts, even if currently not actively draining; visible fibrosis or significant skin thickening in affected areas; a history of slow or incomplete healing following lesion resolution; new lesion formation that appears to originate within or adjacent to previously healed areas; and the persistence of local discomfort, tenderness, or a sense of subcutaneous tension in affected regions even during quiescent periods.
None of these features is a reason for pessimism. They are clinical information — indicators of the depth of the disease that allow the treatment to be matched appropriately. A patient who presents with these features needs the same internal correction as a patient who does not, plus the additional tissue-restoration work that the structural involvement requires. The treatment is more extensive; the timeline is longer. But the principle is the same: identify the depth of involvement, engage with all of its dimensions, and allow adequate time for genuine correction at each level.
"When a condition keeps recurring, it usually follows an underlying pattern that needs to be understood and addressed — not suppressed."
What Tissue Restoration Requires
Tissue restoration in the context of deep-seated HS pathology is not a passive process. It is an active, directed effort to support the regeneration of tissue that has been altered by sustained inflammation. This requires, first, that the systemic inflammatory environment has been sufficiently reduced — because tissue restoration in an environment of ongoing high inflammation is counterproductive; the inflammation continues to damage what is being rebuilt. This is why tissue restoration appears in the middle phases of the EPOH approach, after the foundational work of gut restoration and inflammation reduction has created the internal conditions in which regeneration can occur.
It then requires specific support for the regenerative processes of the affected tissue layers: promoting normal collagen remodelling in fibrosed areas, supporting vascular and lymphatic restoration in zones of impaired drainage, and providing the nutritive substrate — the Rasayana dimension — that allows the depleted Dhatu to regenerate with genuine functional quality rather than simply filling the depleted space with scar-like replacement tissue.
This is not a short process. Tissue regeneration operates at the pace of cellular renewal cycles — months, not weeks. For patients with significant structural involvement, understanding this timeline is essential for maintaining the sustained commitment that genuine tissue restoration requires. The outcome — tissue that has actually regenerated rather than simply scarred over — is worth the time it takes. But it requires that the process be understood, sustained, and allowed to complete.